Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease (Q33373539)

26 July 2017

1 reference

title

Acquired idiopathic thrombotic thrombocytopenic purpura: arguments for an autoimmune disease (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

0 references

1 reference

1 reference

1 reference

2

Agnès Veyradier

0 references

author name string

Paul Coppo

1

1 reference

26 July 2017

Agnès Veyradier

2

1 reference

26 July 2017

Matthieu Monge

3

1 reference

26 July 2017

Réseau d'Etude des Microangiopathies Thrombotiques

4

1 reference

26 July 2017

language of work or name

French

0 references

publication date

1 December 2006

1 reference

26 July 2017

1 reference

26 July 2017

35

1 reference

26 July 2017

12 Pt 2

1 reference

26 July 2017

1876-1886

1 reference

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

1 reference

7 January 2021

Inducible secretion of large, biologically potent von Willebrand factor multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Case series of thrombotic thrombocytopenic purpura in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Systemic lupus erythematosus complicated by thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Renal vascular lesions in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Endothelium as a target for antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Renal manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Anti-CD36 antibodies in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Control of von Willebrand factor multimer size by thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Haemolytic uraemic syndrome is an immune-mediated disease: role of anti-CD36 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

HLA-DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Estrogen alters thresholds for B cell apoptosis and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Endothelial cell gene expression in response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

A role for Toll in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

Levels of soluble Fas/APO-1 in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974920-X

7 January 2021

10.1016/S0755-4982(06)74920-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72zkzkfxbnhdpfjyhtxb7mzbe4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_72zkzkfxbnhdpfjyhtxb7mzbe4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72zkzkfxbnhdpfjyhtxb7mzbe4

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/72zkzkfxbnhdpfjyhtxb7mzbe4

30 July 2022